A new study published in the journal Gastroenterology and Hepatology suggests that patients suffering from inflammatory bowel disease (IBD) may benefit by restarting infliximab therapy after dropping out of the therapy previously. "Our findings suggest that starting infliximab after a history of prior therapy can be very beneficial to patients," said lead study author Filip Baert, MD, PhD, from the department of gastroenterology, University Hospitals Leuven in Belgium. ...
Read More
You have just read an article categorized health
titled Resuming Infliximab Therapy After Stopping It can be 'Very Beneficial' for IBD Patients.
Written by:
editor -
Saturday, September 6, 2014
There are currently no comments for "Resuming Infliximab Therapy After Stopping It can be 'Very Beneficial' for IBD Patients"
Post a Comment